{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:48:15Z","timestamp":1793760495450,"version":"4.6.1"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>Iron is essential for vital cellular processes, including DNA synthesis, repair, and proliferation, necessitating enhanced iron uptake and intracellular accumulation. Tumor cells, in particular, exhibit a pronounced elevation in iron uptake to sustain their continuous proliferation, migration and invasion. This elevated iron acquisition is facilitated predominantly through the upregulation of transferrin receptors, which are closely associated with tumorigenesis and tumor progression. Incorporating transferrin into drug delivery systems has been shown to enhance cytotoxic effects in drug-sensitive cancer cells, offering a potential method to surpass the limitations of current cancer therapies. Intracellular iron predominantly exists as ferritin heavy chain (FTH), ferritin light chain (FTL), and labile iron pool (LIP). The innovation of nanocarriers incorporating iron chelating agents has attracted considerable interest. Iron chelators such as Deferoxamine (DFO), Deferasirox (DFX), and Dp44mT have demonstrated significant promise in cancer treatment by inducing iron deficiency within tumor cells. This review explores recent advancements in nanotechnology aimed at targeting iron metabolism in cancer cells and discusses their potential applications in cancer treatment strategies.<\/jats:p>","DOI":"10.3389\/fbioe.2025.1511197","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T07:57:04Z","timestamp":1741766224000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Nanomaterials targeting iron homeostasis: a promising strategy for cancer treatment"],"prefix":"10.3389","volume":"13","author":[{"given":"Bin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yantao","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molcel.2023.11.040","article-title":"The biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death","volume":"84","author":"Ai","year":"2024","journal-title":"Mol. Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1515\/dmpt-2018-0032","article-title":"Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles","volume":"34","author":"Alavi","year":"2019","journal-title":"Drug Metab. Pers. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12951-022-01243-w","article-title":"Ultrasound and nanomaterial: an efficient pair to fight cancer","volume":"20","author":"Alphandery","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3390\/nu12051515","article-title":"The action of JAK\/STAT3 and BMP\/HJV\/SMAD signaling pathways on hepcidin suppression by tucum-do-cerrado in a normal and iron-enriched diets","volume":"12","author":"Arruda","year":"2020","journal-title":"Nutrients"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3390\/cells8101158","article-title":"Nanoparticles targeting STATs in cancer therapy","volume":"8","author":"Ashrafizadeh","year":"2019","journal-title":"Cells"},{"key":"B6","doi-asserted-by":"publisher","first-page":"20150207","DOI":"10.1259\/bjr.20150207","article-title":"Applications of nanoparticles for diagnosis and therapy of cancer","volume":"88","author":"Baetke","year":"2015","journal-title":"Br. J. Radiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41388-023-02933-x","article-title":"DMT1-dependent endosome-mitochondria interactions regulate mitochondrial iron translocation and metastatic outgrowth","volume":"43","author":"Barra","year":"2024","journal-title":"Oncogene"},{"key":"B8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.tibtech.2020.11.005","article-title":"Overcoming challenges in expressing iron-sulfur enzymes in yeast","volume":"39","author":"Biz","year":"2021","journal-title":"Trends Biotechnol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1385\/bter:92:3:189","article-title":"Current knowledge of iron metabolism","volume":"92","author":"Boccio","year":"2003","journal-title":"Biol. Trace Elem. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.biocel.2019.02.002","article-title":"Extracellular matrix-mediated regulation of cancer stem cells and chemoresistance","volume":"109","author":"Brown","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.607692","article-title":"Antibodies targeting the transferrin receptor 1 (TfR1) as direct anti-cancer agents","volume":"12","author":"Candelaria","year":"2021","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jinorgbio.2014.01.007","article-title":"Regulation of iron transport systems in Enterobacteriaceae in response to oxygen and iron availability","volume":"133","author":"Carpenter","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"9142","DOI":"10.1523\/jneurosci.1447-18.2018","article-title":"The divalent metal transporter 1 (DMT1) is required for iron uptake and normal development of oligodendrocyte progenitor cells","volume":"38","author":"Cheli","year":"2018","journal-title":"J. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1002\/jcp.30060","article-title":"Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma","volume":"236","author":"Chen","year":"2021","journal-title":"J. Cell Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.1074\/jbc.m114.547778","article-title":"Iron regulatory protein-1 protects against mitoferrin-1-deficient porphyria","volume":"289","author":"Chung","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"15231","DOI":"10.3390\/ijms242015231","article-title":"Assessing the potential of small peptides for altering expression levels of the iron-regulatory genes FTH1 and TFRC and enhancing androgen receptor inhibitor activity in in vitro prostate cancer models","volume":"24","author":"Currie","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-nutr-062320-112625","article-title":"Molecular mechanisms of iron and heme metabolism","volume":"42","author":"Dutt","year":"2022","journal-title":"Annu. Rev. Nutr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"8031","DOI":"10.1073\/pnas.1402732111","article-title":"Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase","volume":"111","author":"Frey","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-981-13-9589-5_2","article-title":"Cellular iron metabolism and regulation","volume":"1173","author":"Gao","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1158\/1541-7786.mcr-11-0281","article-title":"STEAP proteins: from structure to applications in cancer therapy","volume":"10","author":"Gomes","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/mc.22474","article-title":"Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate","volume":"56","author":"Greenshields","year":"2017","journal-title":"Mol. Carcinog."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1172\/jci99032","article-title":"Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma","volume":"128","author":"Hassannia","year":"2018","journal-title":"J. Clin. Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1098501","DOI":"10.3389\/fonc.2023.1098501","article-title":"Iron metabolism in colorectal cancer","volume":"13","author":"Huang","year":"2023","journal-title":"Front. Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10534-020-00243-3","article-title":"Iron chelators in cancer therapy","volume":"33","author":"Ibrahim","year":"2020","journal-title":"Biometals"},{"key":"B25","doi-asserted-by":"publisher","first-page":"6028","DOI":"10.1007\/s12010-023-04828-9","article-title":"Rosmarinic acid liposomes downregulate hepcidin expression via BMP6-SMAD1\/5\/8 pathway in mice with iron overload","volume":"196","author":"Jia","year":"2024","journal-title":"Appl. Biochem. Biotechnol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2174\/1567201819666220509164611","article-title":"Super para-magnetic iron oxide nanoparticles (SPIONs) in the treatment of cancer: challenges, approaches, and its pivotal role in pancreatic, colon, and prostate cancer","volume":"20","author":"Khan","year":"2023","journal-title":"Curr. Drug Deliv."},{"key":"B27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nnano.2016.164","article-title":"Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth","volume":"11","author":"Kim","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1006\/excr.1996.0343","article-title":"Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D\/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells","volume":"229","author":"Kulp","year":"1996","journal-title":"Exp. Cell Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1021\/acsnano.8b08823","article-title":"Targeted Co-delivery of the iron chelator deferoxamine and a HIF1\u03b1 inhibitor impairs pancreatic tumor growth","volume":"13","author":"Lang","year":"2019","journal-title":"ACS Nano"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s13577-023-00890-x","article-title":"Promotion of ferroptosis in head and neck cancer with divalent metal transporter 1 inhibition or salinomycin","volume":"36","author":"Lee","year":"2023","journal-title":"Hum. Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e83053","DOI":"10.7554\/elife.83053","article-title":"Structures of ferroportin in complex with its specific inhibitor vamifeport","volume":"12","author":"Lehmann","year":"2023","journal-title":"Elife"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.biocel.2003.10.020","article-title":"Mitochondrial ferritin","volume":"36","author":"Levi","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e2105451","DOI":"10.1002\/advs.202105451","article-title":"Synchronous disintegration of ferroptosis defense Axis via engineered exosome-conjugated magnetic nanoparticles for glioblastoma therapy","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jtemb.2019.01.004","article-title":"Desferrioxamine-caffeine shows improved efficacy in chelating iron and depleting cancer stem cells","volume":"52","author":"Li","year":"2019","journal-title":"J. Trace Elem. Med. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41419-023-05972-0","article-title":"HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-\u03baB signaling pathway in breast cancer","volume":"14","author":"Liang","year":"2023","journal-title":"Cell Death Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1078137","DOI":"10.3389\/fbioe.2022.1078137","article-title":"A DFX-based iron nanochelator for cancer therapy","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/bph.15986","article-title":"Artesunate, a new antimalarial clinical drug, exhibits potent anti-AML activity by targeting the ROS\/Bim and TFRC\/Fe(2+) pathways","volume":"180","author":"Liu","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2014.01.029","article-title":"Iron homeostasis in breast cancer","volume":"347","author":"Marques","year":"2014","journal-title":"Cancer Lett."},{"key":"B39","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.7150\/thno.59092","article-title":"Targeting iron metabolism in cancer therapy","volume":"11","author":"Morales","year":"2021","journal-title":"Theranostics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.3390\/ijms22126493","article-title":"Hepcidin-ferroportin interaction controls systemic iron homeostasis","volume":"22","author":"Nemeth","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2174\/1381612822666161026162347","article-title":"Transferrin-conjugated nanocarriers as active-targeted drug delivery platforms for cancer therapy","volume":"23","author":"Nogueira-Librelotto","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"B43","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41419-019-2064-5","article-title":"ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation","volume":"10","author":"Park","year":"2019","journal-title":"Cell Death Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"133323","DOI":"10.1016\/j.ijbiomac.2024.133323","article-title":"Expression of transferrin receptor\/TFRC protein in bladder cancer cell T24 and its role in inducing iron death in bladder cancer","volume":"274","author":"Qin","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.36255\/exonpublications.prostatecancer.steap.2021","article-title":"The usefulness of STEAP proteins in prostate cancer clinical practice","volume-title":"Prostate cancer","author":"Rocha","year":"2021"},{"key":"B46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/ijms24010449","article-title":"Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis","volume":"24","author":"Rochette","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0182954","DOI":"10.1371\/journal.pone.0182954","article-title":"Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: expression and prognostic value","volume":"12","author":"Rosager","year":"2017","journal-title":"PLoS One"},{"key":"B48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/bs.vh.2019.01.005","article-title":"Regulators of hepcidin expression","volume":"110","author":"Roth","year":"2019","journal-title":"Vitam. Horm."},{"key":"B49","doi-asserted-by":"publisher","first-page":"711227","DOI":"10.3389\/fmolb.2021.711227","article-title":"Role of copper on mitochondrial function and metabolism","volume":"8","author":"Ruiz","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1172\/jci90519","article-title":"PCBP1 and NCOA4 regulate erythroid iron storage and heme biosynthesis","volume":"127","author":"Ryu","year":"2017","journal-title":"J. Clin. Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.semcancer.2021.04.001","article-title":"Role of iron in cancer","volume":"76","author":"Salnikow","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"22865","DOI":"10.1074\/jbc.m603876200","article-title":"Iron regulation and the cell cycle: identification of an iron-responsive element in the 3'-untranslated region of human cell division cycle 14A mRNA by a refined microarray-based screening strategy","volume":"281","author":"Sanchez","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"R1292","DOI":"10.1016\/j.cub.2020.09.068","article-title":"Ferroptosis","volume":"30","author":"Tang","year":"2020","journal-title":"Curr. Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.3390\/ijms22094591","article-title":"On iron metabolism and its regulation","volume":"22","author":"Vogt","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.canlet.2016.08.006","article-title":"EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1","volume":"381","author":"Wang","year":"2016","journal-title":"Cancer Lett."},{"key":"B57","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jtemb.2019.07.008","article-title":"The iron chelator desferrioxamine synergizes with chemotherapy for cancer treatment","volume":"56","author":"Wang","year":"2019","journal-title":"J. Trace Elem. Med. Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"127060","DOI":"10.1016\/j.jtemb.2022.127060","article-title":"Role of iron biomarkers and iron intakes in lung cancer risk: a systematic review and meta-analysis","volume":"74","author":"Wang","year":"2022","journal-title":"J. Trace Elem. Med. Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2018.07.020","article-title":"DMT1 and iron transport","volume":"133","author":"Yanatori","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"756895","DOI":"10.3389\/fmolb.2022.756895","article-title":"Role of TFRC as a novel prognostic biomarker and in immunotherapy for pancreatic carcinoma","volume":"9","author":"Yang","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e23550","DOI":"10.1096\/fj.202302597r","article-title":"Correlation between ferroptosis and adriamycin resistance in breast cancer regulated by transferrin receptor and its molecular mechanism","volume":"38","author":"Yu","year":"2024","journal-title":"FASEB J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3390\/pharmaceutics13111785","article-title":"Nanoparticles for ferroptosis therapy in cancer","volume":"13","author":"Zaffaroni","year":"2021","journal-title":"Pharmaceutics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/cgt.2017.16","article-title":"New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles","volume":"24","author":"Zaimy","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"20230882","DOI":"10.1515\/med-2023-0882","article-title":"METTL3 attenuates ferroptosis sensitivity in lung cancer via modulating TFRC","volume":"19","author":"Zhang","year":"2024","journal-title":"Open Med. (Wars)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","article-title":"Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Chem. Biol."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2025.1511197\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T07:57:09Z","timestamp":1741766229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2025.1511197\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":65,"alternative-id":["10.3389\/fbioe.2025.1511197"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2025.1511197","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"article-number":"1511197"}}